-
Study aim
-
Comparison of the effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function and its areas in people with metabolic syndrome.
-
Design
-
Randomized controlled clinical trial, with factorial groups, without blinding, phase 3 will be conducted on 84 patients with metabolic syndrome, random number table will be used for randomization.
-
Settings and conduct
-
This study will be conducted on people who visit the diabetes clinic. The people participating in the study will be divided into 3 groups and will be controlled for 12 weeks the two intervention groups will be given the usual food recommendations as well as the control group, and no calorie restriction will be considered for any of the three groups. At the beginning and end of the study, metabolic syndrome indices and cognitive function will be measured.
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria:
Having informed consent
Adults (18-60 years old)
have metabolic syndrome.
Non-entry criteria:
. Suffering from thyroid diseases, anemia, diabetes, neurological and psychiatric illnesses
. Have a stroke or transient ischemic attack in the last 3 months.
. History of brain damage, liver and kidney illnesses, HIV
. Have been diagnosed with cancer in the last five years.
. Obese people with a BMI higher than 40
-
Intervention groups
-
One intervention group will receive the MIND diet + placebo, the other group, which is also the intervention group, will receive the MIND diet + propolis supplement, and the next group, which is the control group, will receive microcrystalline cellulose placebo + usual dietary advice.
-
Main outcome variables
-
metabolic syndrome indices and cognitive function